Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 1
1993 1
1995 3
1996 3
1997 1
1998 2
2001 1
2003 2
2004 2
2005 1
2006 4
2007 6
2008 4
2009 1
2010 1
2011 1
2012 1
2013 2
2014 5
2015 3
2016 2
2017 3
2018 1
2019 3
2020 2
2021 1
2022 1
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators. Chi KN, et al. N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150574 Free article. Clinical Trial.
Incidental diagnosis of bladder cancer in a national observational study in spain.
Gaya JM, Territo A, Woldu S, Schwartzmann I, Verri P, González-Pérez L, Cózar JM, Miñana B, Medina RA, de la Rosa-Kehrmann F, Lozano-Palacio F, Ribal MJ, Hernández C, Castiñeiras JJ, Requena MJ, Moreno J, Caraballido JA, Baena V, Breda A, Palou Redorta J. Gaya JM, et al. Among authors: requena mj. Actas Urol Esp (Engl Ed). 2023 Jun;47(5):296-302. doi: 10.1016/j.acuroe.2022.09.005. Epub 2022 Oct 1. Actas Urol Esp (Engl Ed). 2023. PMID: 36443223 English, Spanish.
FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
Blanca A, Requena MJ, Alvarez J, Cheng L, Montironi R, Raspollini MR, Reymundo C, Lopez-Beltran A. Blanca A, et al. Among authors: requena mj. Biomark Med. 2016;10(3):243-53. doi: 10.2217/bmm.15.120. Epub 2016 Feb 9. Biomark Med. 2016. PMID: 26861974
Hepatoid adenocarcinoma of the urinary bladder.
Lopez-Beltran A, Luque RJ, Quintero A, Requena MJ, Montironi R. Lopez-Beltran A, et al. Among authors: requena mj. Virchows Arch. 2003 Apr;442(4):381-7. doi: 10.1007/s00428-003-0772-8. Epub 2003 Mar 25. Virchows Arch. 2003. PMID: 12715173
Plasmacytoid urothelial carcinoma of the bladder.
Lopez-Beltran A, Requena MJ, Montironi R, Blanca A, Cheng L. Lopez-Beltran A, et al. Among authors: requena mj. Hum Pathol. 2009 Jul;40(7):1023-8. doi: 10.1016/j.humpath.2009.01.001. Epub 2009 Mar 17. Hum Pathol. 2009. PMID: 19297008
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness.
Hormaechea-Agulla D, Gahete MD, Jiménez-Vacas JM, Gómez-Gómez E, Ibáñez-Costa A, L-López F, Rivero-Cortés E, Sarmento-Cabral A, Valero-Rosa J, Carrasco-Valiente J, Sánchez-Sánchez R, Ortega-Salas R, Moreno MM, Tsomaia N, Swanson SM, Culler MD, Requena MJ, Castaño JP, Luque RM. Hormaechea-Agulla D, et al. Among authors: requena mj. Mol Cancer. 2017 Aug 29;16(1):146. doi: 10.1186/s12943-017-0713-9. Mol Cancer. 2017. PMID: 28851363 Free PMC article.
Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance.
Salguero J, Gómez-Gómez E, Valero-Rosa J, Carrasco-Valiente J, Mesa J, Martin C, Campos-Hernández JP, Rubio JM, López D, Requena MJ. Salguero J, et al. Among authors: requena mj. Korean J Radiol. 2021 Apr;22(4):559-567. doi: 10.3348/kjr.2020.0852. Epub 2020 Nov 26. Korean J Radiol. 2021. PMID: 33289358 Free PMC article.
Rituximab, interferon-alfa-2b and dose dense CVP is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the LNH-PRO-05 study.
Cannata-Ortiz J, Nicolás C, García-Noblejas A, Requena MJ, López-Jiménez J, Alaez Uson C, Arranz R. Cannata-Ortiz J, et al. Among authors: requena mj. Br J Haematol. 2019 Jul;186(1):168-170. doi: 10.1111/bjh.15760. Epub 2019 Jan 17. Br J Haematol. 2019. PMID: 30656671 Free article. No abstract available.
54 results